Publication details

Enhancing the utility of chromosome 6 and 8 testing in uveal melanoma biopsies

Authors

MATUŠKOVÁ Veronika HORŇÁČKOVÁ Pavla MICHALEC Marek ZLÁMALÍKOVÁ Lenka MATULOVÁ Květoslava UHER Michal

Year of publication 2024
Type Article in Periodical
Magazine / Source Biomedical Papers
MU Faculty or unit

Faculty of Medicine

Citation
Web https://biomed.papers.upol.cz/corproof.php?tartkey=bio-000000-3672
Doi http://dx.doi.org/10.5507/bp.2024.018
Keywords uveal melanoma; chromosome 6; chromosome 8; CISH, FISH; progression free survival
Description Background: The aim of this study was to evaluate the significance of testing the gain of chromosome 8 and the gain of chromosome 6 as prognostic markers in histopathological samples of enucleated eyes in with uveal melanoma. Methods: This is a retrospective study of 54 enucleated eyes. The status of chromosomes 3, 8 and 6 was tested by CISH, and FISH was used in a few samples. A follow-up for the detection of metastases was conducted in all patients. The statistical significance of chromosomal abnormalities as a prognostic factor for the development of metastases was determined. Results: The study group consists of 54 patients (average age 63 years), 28 men (51.9%) Monosomy 3 together with gain of chromosome 8 was found in 10 samples (18.5%). Both chromosomal abnormalities were detected in 6 (11%) patients. No chromosomal abnormality in 3 or 8 was detected in 21 (38.9%) patients. Abnormalities of chromosome 6 were present in 6 (11%) patients. Progression free survival after 5 years was 33.3% (95% CI 0.0; 83.3) in these patients. Conclusions: Our findings indicate a correlation between progression-free survival and the presence of changes in chromosome 3 and e 8 in uveal melanomas. The results underline the necessity of testing for both chromosomal aberrations.

You are running an old browser version. We recommend updating your browser to its latest version.

More info